EUVIMEDEUVIMED entdecken
Crossref

MCAM is a prognostic serum biomarker in patients with liver cirrhosis and HCC

Mikhail Gromak, Hendrik Luxenburger, Tobias Böttler, Robert Thimme, Maike Hofmann, Natascha Roehlen

Zeitschrift für Gastroenterologie · 01.01.2023 · 61 (01) · e19

DOI: 10.1055/s-0042-1759952 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Zeitschrift für Gastroenterologie, erschienen am 01.01.2023. Verfasst von Mikhail Gromak und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic liver diseases are a major public health burden. The rising incidence of patients with liver cirrhosis and hepatocellular carcinoma (HCC) emphasizes the need for non-invasive markers that predict poor prognosis. Melanoma cell adhesion molecule (MCAM) is a cell surface adhesion molecule expressed by diverse cell types. MCAM cleavage by metalloproteinases, known to be enriched in fibrotic and malignant diseases, results in release of a soluble form into the serum. The aim of this study was to evaluate soluble MCAM as a prognostic serum biomarker in patients with chronic liver disease. Interestingly, we found serum levels of MCAM to be highly dysregulated in patients with liver cirrhosis and HCC (n=302 and n=54, p 1216 ng/ml showed a more than 14 times higher risk of death within 5 year’s follow up compared to patients with lower levels (p=0.001, log-rank test). Collectively, our study reveals MCAM as a novel prognostic serum biomarker in patients with liver cirrhosis and patients with HCC. Publication History Article published online: 18 January 2023 © 2023. Thieme. All rights reserved. Georg Thieme Verlag Rüdigerstraße 14, 70469 Stuttgart, Germany

Zitieren

APA

Gromak, M., Luxenburger, H., Böttler, T., Thimme, R., Hofmann, M., & Roehlen, N. (2023). MCAM is a prognostic serum biomarker in patients with liver cirrhosis and HCC. Zeitschrift für Gastroenterologie, 61(01), e19. https://doi.org/10.1055/s-0042-1759952

Vancouver

Gromak M, Luxenburger H, Böttler T, Thimme R, Hofmann M, Roehlen N. MCAM is a prognostic serum biomarker in patients with liver cirrhosis and HCC. Zeitschrift für Gastroenterologie. 2023;61(01):e19. doi:10.1055/s-0042-1759952

BibTeX
@article{Gromak2023,
  author = {Gromak, Mikhail and Luxenburger, Hendrik and Böttler, Tobias and Thimme, Robert and Hofmann, Maike and Roehlen, Natascha},
  title = {MCAM is a prognostic serum biomarker in patients with liver cirrhosis and HCC},
  journal = {Zeitschrift für Gastroenterologie},
  year = {2023},
  volume = {61},
  number = {01},
  pages = {e19},
  doi = {10.1055/s-0042-1759952}
}
Kostenlos starten →